Nutrient quality
Rhodiola rosea is named, but the whole-root ingredient lacks active-marker standardization. The very large extended-release amount is difficult to justify without potency data.
.| $ 39.06 | ||
| $ 33.20 | ||
Vitacost | $ 39.06 |
The tablet confirms Rhodiola rosea and uses extended release for prolonged delivery. That format may suit people seeking steadier daytime exposure rather than a short peak.
The 1,000 mg amount appears to be unstandardized whole root, with no rosavin or salidroside levels. Raw root weight cannot be compared directly with characterized extracts, so true active strength remains uncertain.
A tiny whole-food complex adds little assessable value, and the serving cost is relatively high. Extended exposure can also prolong activating effects if the amount does not suit the user.
Rhodiola rosea is named, but the whole-root ingredient lacks active-marker standardization. The very large extended-release amount is difficult to justify without potency data.
.A proprietary or composite ingredient hides meaningful component doses. Missing excipient details and complete use directions leave the supplied label information incomplete.
.The supplied aggregate satisfaction average is favorable, while the response volume determines how stable that signal appears. No comment-level evidence is available to assess repeated complaints or confirm intended-use experiences.
.Quality, disclosure, or serving economics materially weaken value. The undefined whole-food complex adds little assessable value.
.Rhodiola is a targeted adaptogen that may improve stress resilience and fatigue under demanding conditions. Its evidence is supportive but less consistent than the best-studied standardized stress extracts.
The 1,000 mg amount is substantial and extended release may spread delivery, but no rosavin or salidroside standardization is stated. Rhodiola can feel activating and may worsen agitation or mania in susceptible users.
Rhodiola is directly relevant to stress-related fatigue and mental endurance. Extended release may provide steadier exposure than an ordinary tablet.
The very large whole-root amount is not standardized to rosavins or salidroside, so potency cannot be compared reliably with studied extracts. The high amount may also raise the chance of irritability or insomnia in sensitive users.
Rhodiola rosea may support attention and mental endurance during stress-related fatigue. Human evidence is useful but depends heavily on standardized extracts with known rosavin and salidroside content.
The extended-release whole-root amount is very large, yet missing active-marker disclosure makes potency hard to predict. Rhodiola at this amount may cause irritability or insomnia, particularly in sensitive users or people prone to manic symptoms.
Rhodiola rosea directly targets stress-related fatigue and resilience, giving the formula strong goal relevance. The species is appropriate, but evidence depends heavily on standardized extracts rather than an unspecified whole-root amount.
The very large serving and extended-release format may provide prolonged exposure, yet missing rosavin and salidroside data make potency difficult to judge. The high amount may cause irritability or insomnia in sensitive users, especially when taken late in the day.
Rhodiola rosea may support mental stamina and concentration when stress or fatigue is the main barrier. Extended release may spread exposure, but it does not resolve uncertainty about the unstandardized whole-root form.
The 1,000 mg amount exceeds preferred standardized-extract ranges and may be difficult to predict. Sensitive users may experience irritability or insomnia, especially when the tablet is taken late in the day.
Rhodiola rosea may support mental endurance and reduce cognitive fatigue under stress. Its role is useful but narrower than comprehensive brain support.
The 1,000 mg extended-release amount is unusually high and lacks rosavin and salidroside standardization. A high rhodiola serving may cause irritability or insomnia even with extended release.
| Ingredient | Amount per serving |
|---|---|
Rhodiola (Rhodiola rosea) | 1000 mg |
Active Whole Food Complex | 100 mcg |
The label confirms Rhodiola rosea but presents it as an unstandardized whole-root ingredient. Its very large amount sits above the preferred range even with extended release. Irritability or insomnia remains a practical concern, while missing active-marker data prevents a reliable value assessment.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.